Global Gene-Editing Transfection Chemical Market Growth 2025-2031

The global Gene-Editing Transfection Chemical market size is predicted to grow from US$ 1100 million in 2025 to US$ 1724 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Gene-Editing Transfection Chemicals are specialized reagents or compounds used to introduce gene-editing components—such as CRISPR-Cas9 systems, plasmids, mRNA, or ribonucleoprotein (RNP) complexes—into living cells. These chemicals play a vital role in ensuring the efficient, safe, and reproducible delivery of genetic materials across various cell types, including difficult-to-transfect primary cells, stem cells, and cancer lines. The delivery process, known as transfection, is critical for enabling gene-editing tools to access the genome and perform targeted modifications.

United States market for Gene-Editing Transfection Chemical is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Gene-Editing Transfection Chemical is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Gene-Editing Transfection Chemical is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Gene-Editing Transfection Chemical players cover Thermo Fisher Scientific, Merck, GE Healthcare, Qiagen, Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Gene-Editing Transfection Chemical Industry Forecast” looks at past sales and reviews total world Gene-Editing Transfection Chemical sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene-Editing Transfection Chemical sales for 2025 through 2031. With Gene-Editing Transfection Chemical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-Editing Transfection Chemical industry.

This Insight Report provides a comprehensive analysis of the global Gene-Editing Transfection Chemical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene-Editing Transfection Chemical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-Editing Transfection Chemical market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-Editing Transfection Chemical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-Editing Transfection Chemical.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene-Editing Transfection Chemical market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Lipid-Based Transfection Reagents
Polymer-Based Transfection Reagents
Lipid-Polymer Hybrid Reagents
Cell-Penetrating Peptides
Others

Segmentation by Application:
Biomedical Research
Drug Discovery
Disease Modeling
Agricultural Biotechnology
Vaccine Development
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
GE Healthcare
Qiagen
Bio-Rad Laboratories
Takara
Invitrogen
Roche
Agilent Technologies
Lonza
Santa Cruz Biotechnology
New England Biolabs
Promega Corporation
Polyplus-transfection
TransGen Biotech
GenScript Biotech Corporation
Abcam
Bio-Techne Corporation
Cell Signaling Technology
Creative Biogene
AAT Bioquest
Precision NanoSystems

Key Questions Addressed in this Report

What is the 10-year outlook for the global Gene-Editing Transfection Chemical market?

What factors are driving Gene-Editing Transfection Chemical market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Gene-Editing Transfection Chemical market opportunities vary by end market size?

How does Gene-Editing Transfection Chemical break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more